Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. BASF SE
  6. News
  7. Summary
    BAS   DE000BASF111

BASF SE

(BAS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BASF : strengthens its global production footprint for enzymes

05/06/2021 | 08:40am EDT

On April 26, 2021 BASF has agreed with Sandoz GmbH, a subsidiary of Novartis, to invest at the Kundl/Schaftenau Campus in Austria. This agreement enables BASF to further develop its production footprint for enzymes and biotechnology products. Both parties agreed not to disclose financial details of the agreement.

'This investment is a clear sign of our commitment to the enzymes and biotechnology industry. BASF will strengthen its position in the market, as the Kundl/Schaftenau Campus has 75 years of biotechnology practice and corresponding infrastructure, including deep know-how,' said Dr. Michael De Marco, Vice President Global Business Management Enzymes for BASF.

'The agreement enables us to expand our production footprint for detergent enzymes and further enhance our product portfolio and leading market position in the Home Care and I&I industry,' said Dr. Soeren Hildebrandt, Senior Vice President Home Care, I&I and Industrial Formulators Europe. 'With this step we support our customers to address key market needs such as cleaning products with superior sustainability profiles and new product formats, based on innovative BASF enzyme technology.'

'Tyrol is a key location for our global production network. Our investments in Kundl and Schaftenau reinforce our commitment to the region,' says Steffen Lang, Head of Novartis Technical Operations and member of the Novartis Executive Committee. 'With the further development into a Life Science Park and the settlement of BASF, an important player in the field of biotechnology, we are strengthening the competence and innovation capacity of the area.'

BASF seeks also to explore the potential to grow further via deeper involvement in the Kundl/Schaftenau Campus. The start of production is planned for 2024.

Contact:

T: 91 22 67127600

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about BASF SE
10:27aGLOBAL MARKETS LIVE : Microsoft, HSBC, RyanAir, CureVac, Wise...
05:50aBASF SE  : UBS reaffirms its Buy rating
MD
05:06aBASF  : First vegetable seeds grown in BASF's new state-of-the-art production fa..
PU
06/16BASF SE  : Baader Bank reiterates its Buy rating
MD
06/16BASF Delays Wintershall Dea IPO Back on Oil-And-Gas Conditions
DJ
06/16BASF  : LetterOne To Delay Wintershall Dea's IPO
MT
06/16BASF  : IPO of Wintershall Dea will be targeted post 2021
PU
06/15Volkswagen seeks partners for battery materials race
RE
06/14DGAP-DD  : BASF SE english
DJ
06/14BASF  : receives GMP+ and ISO 22000 certifications for its glycerin production a..
PU
More news
Financials
Sales 2021 67 947 M 80 990 M 80 990 M
Net income 2021 4 054 M 4 833 M 4 833 M
Net Debt 2021 14 732 M 17 560 M 17 560 M
P/E ratio 2021 14,8x
Yield 2021 5,12%
Capitalization 60 721 M 72 347 M 72 376 M
EV / Sales 2021 1,11x
EV / Sales 2022 1,11x
Nbr of Employees 110 261
Free-Float 100%
Chart BASF SE
Duration : Period :
BASF SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BASF SE
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 77,45 €
Last Close Price 66,47 €
Spread / Highest target 58,0%
Spread / Average Target 16,5%
Spread / Lowest Target -12,7%
EPS Revisions
Managers and Directors
NameTitle
Martin Brudermüller Chairman-Executive Board
Hans-Ulrich Engel Chief Financial & Digital Officer
Kurt Wilhelm Bock Chairman-Supervisory Board
Melanie Maas-Brunner Chief Technology Officer
Anke Schäferkordt Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BASF SE2.70%73 984
SHIN-ETSU CHEMICAL CO., LTD.4.66%72 137
DUPONT DE NEMOURS, INC.12.77%42 672
ROYAL DSM N.V.9.34%32 023
EVONIK INDUSTRIES AG7.23%16 156
ASAHI KASEI CORPORATION16.93%15 833